Because CXCL14, CCL20, CCL24, and CCL26 exerted significant roles in PCa, the CRPGS was established based on the four identified chemokine genes, and PCa patients with high riskscores exhibited poorer survival than patients with low riskscores. The gene discussed is CXCL14; the disease is posterior cortical atrophy.